ConductScience.org, home

Paper8586751

A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.

Sharquie KE. J Dermatol, 1995. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution. Papers, record 8586751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8586751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.
PubMed
Journal
J Dermatol
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2019-08-25
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharquie KEK E

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiprotozoal AgentsMajor topic
Leishmaniasis, CutaneousMajor topic
Saline Solution, HypertonicMajor topic
Adolescent
Adult
Animals
Antimony Sodium Gluconate
Child
Child, Preschool
Cicatrix
Cytoplasm
Female
Follow-Up Studies
Humans
Hyperpigmentation
Injections, Intralesional
Leishmania
Male
Middle Aged
Osmotic Pressure
Remission Induction

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01301924Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous LeishmaniasisBackgroundClinicalTrials.gov
NCT01301937Low Antimonial Dosage in American Mucosal LeishmaniasisBackgroundClinicalTrials.gov

Download CSV of trials

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
37520195In vitro evaluation of herbal based Lesh Nat B cream against Leishmania tropica.J Parasit Dis2023https://conductscience.org/library/papers/37520195PubMed
32873242Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis.BMC Infect Dis2020https://conductscience.org/library/papers/32873242PubMed
29192424Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29192424PubMed
29149474Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29149474PubMed
25485055Anti Leishmanial Effect of Zinc Sulphate on the Viability of Leishmania tropica and L. major Promastigotes.Jundishapur J Microbiol2014https://conductscience.org/library/papers/25485055PubMed
24787001Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/24787001PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8586751

GET https://conductscience.org/api/papers/v1/8586751/authors